Category Archives: Nano medicine

Global Nanomedicine in Central Nervous System Injury and Repair Market, By Product (Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, Vaccines), Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

The nanomedicine in central nervous system injury and repair market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 51,419.82 million by 2028 and grow at a CAGR of 9.91% in the above-mentioned forecast period. Increase in the prevalence of central nervous system diseases such as Parkinsons disease, senile dementia, Alzheimer disease, ocular diseases among others drives the nanomedicine in central nervous system injury and repair market.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nanomedicine-in-central-nervous-system-injury-and-repair-market

Major Players:-

The major players covered in the nanomedicine in central nervous system injury and repair market report are Abbott, Ablynx N.V, California Life Sciences Association, CELGENE CORPORATION, Teva Pharmaceutical Industries Limited, GENERAL ELECTRIC COMPANY, Merck Sharp & Dohme Corp (a subsidiary of Merck & Co., Inc), Pfizer Inc, Nanosphere Inc, Johnson & Johnson Private Limited and BD among other domestic and global players.

Competitive Landscape and Nanomedicine in Central Nervous System Injury and Repair Market Share Analysis

The nanomedicine in central nervous system injury and repair market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to nanomedicine in central nervous system injury and repair market.

Nanomedicine is defined as the nanotechnology which is used for treating, diagnosing, preventing diseases and traumatic injury, and to control of human biological systems using engineered nanodevices and nanostructures at the molecular level. Nanomedicine uses nano-tools that are 1000 times smaller than a cell for treatment of single cell and is also used in polymer therapeutics, regenerative medicine and targeted drug delivery.

Rise in the awareness related to nanomedicine applications is the vital factor escalating the market growth, also rise in thegovernmentfocus in terms of high funding for life science research and technological advancements in manufacturing process of nanomedicine, increase in the use of nanomedicine as probe or contrast agent in medical imaging techniques to extend the application of imaging and to improve the quality of images and rise in the healthcare expenditures are the major factors among others driving the nanomedicine in central nervous system injury and repair market. Moreover, rise in the technological advancements and modernization in the healthcare devices and rise in the risingresearch and developmentactivities in the healthcare sector will further create new opportunities for nanomedicine in central nervous system injury and repair market in the forecasted period of 2021-2028.

For More Insights Get FREE Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-nanomedicine-in-central-nervous-system-injury-and-repair-market

However, high cost associated with nanomedicine based devices, rise in the stringent government regulations and increase in the risk of environment contamination due to release of toxic nanomaterials are the major factors among others which will obstruct the market growth, and will further challenge the growth of nanomedicine in central nervous system injury and repair market in the forecast period mentioned above.

This nanomedicine in central nervous system injury and repair market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nanomedicine in central nervous system injury and repair market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Nanomedicine in Central Nervous System Injury and Repair Market Scope and Market Size

The nanomedicine in central nervous system injury and repair market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

The nanomedicine in central nervous system injury and repair market is also segmented on the basis ofapplicationinto clinical oncology, infectious diseases, clinical cardiology, orthopedics and others.

Nanomedicine in Central Nervous System Injury and Repair Market Country Level Analysis

The nanomedicine in central nervous system injury and repair market is analysed and market size insights and trends are provided by product and application as referenced above.

The countries covered in the nanomedicine in central nervous system injury and repair market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nanomedicine in central nervous system injury and repair market due to rise in the presence of technologically advanced healthcare infrastructure in this region. Asia-Pacific is the expected region in terms of growth in nanomedicine in central nervous system injury and repair market due to rise in the awareness about nanomedicine and high prevalence of chronic diseases in countries in the region.

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT GET FREE COVID-19 SAMPLE@ https://www.databridgemarketresearch.com/covid-19-impact/global-nanomedicine-in-central-nervous-system-injury-and-repair-market

The country section of the nanomedicine in central nervous system injury and repair market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The nanomedicine in central nervous system injury and repair market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for nanomedicine in central nervous system injury and repair market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nanomedicine in central nervous system injury and repair market. The data is available for historic period 2010 to 2019.

Read More @ https://www.databridgemarketresearch.com/reports/global-nanomedicine-in-central-nervous-system-injury-and-repair-market

Customization Available: Global Nanomedicine in Central Nervous System Injury and Repair Market

Data Bridge Market Researchis a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @Corporatesales@databridgemarketresearch.com

Original post:
Nanomedicine in Central Nervous System Injury and Repair Market Report- Trends Key Programs Analysis and Competitive Landscape Analysis The Manomet...

COVID-19s outbreak has coincided with investments flooding into nanomedicine healthcare companies. The World Nano Foundation and Nano Magazine have highlighted a report by marketdataforecast.com that the global nanomedicine market, worth $141.34 billion in 2020, will rise to $258.11bn by 2025.

The report also highlights a huge upsurge of investment support from governments and funds to develop nano therapies for vaccines, diagnostic imaging, regenerative medicine, and drug delivery following the impact of COVID-19.

Furthermore, nanomedicine offers huge advantages for wider healthcare also impacted by the pandemic and Long-COVID after-effects upon cardiovascular, respiratory, neurological, immunological-related diseases.

This aligns with investment monitoring platform Pitchbooks forecast that health tech investment overall will top $10 trillion by 2022 and that nanomedicine investment has grown the sector by 250% in the last five years.

Median nanotech healthcare companies' deal sizes have also doubled since 2019, from 1 million to 2m in the last 12 months, while the number of deals in 2020 was greater than ever, overtaking 100 deals in a single year for the first time.

Investment is already aiding innovation as nanotech researchers and scientists work to improve biomedical devices such as prosthetics, provide new cancer treatments, and develop bone healing therapies, along with more innovations that could transform global healthcare.

Nanotech researchers have found nanobodies that block the COVID-19 and, potentially, other coronaviruses from entering cells and developed mask designs at nanoscale making them both cheaper and more effective.

The fast global response to the pandemic was also enabled by nanotechnology, being pivotal in Pfizer and AstraZeneca vaccine development and Innova Medical Groups 30-minute lateral flow COVID tests.

World Nano Foundation co-founder Paul Stannard said COVID-19 highlighted weaknesses in healthcare systems across the developed world, proving that long-term, innovative solutions are needed to enable change and prevent future pandemics, with nanomedicine playing an ever greater role in this transformation of global healthcare.

And while impressed by rising investments in and recognition for the nanotech sector, he warned against any let-up in this trend:

Nanotechnology is not only crucial to our current healthcare systems, but researchers and scientists in this field are on the cusp of therapies, devices, and innovation that will revolutionize how we move forward.

To ensure pandemic preparedness, high-quality healthcare, and longevity, we must invest in nano healthtech and care innovations.

His message was echoed by Kojo Annan (son of late and former UN secretary-general Kofi Annan) who is a general partner in the Luxembourg-based Vector Innovation Fund, which recently launched a sub-fund raising an initial $300m for pandemic protection and preparedness.

Annan said: A virtuous circle is developing between investment and healthtech.

Lately, we have seen the development of multiple vaccines, acceleration of technologies linked to decoding the genome, the rise of nanomedicine and the use of artificial intelligence to monitor infectious diseases and new pathogens.

More investment in sustainable healthtech funding can only accelerate this trend, bringing fairer and global distribution of healthcare, greater affordability, and preventive and early intervention healthcare, all ultimately improving the longevity of life.

The pandemic has also transformed telemedicine investment and demonstrated that nonsense and innovation could deliver more resilient societies and ecosystems for healthcare.

Written by Steve Philp of The World Nano Foundation.

Korea IT Times

Read the original:
Nanomedicine is transforming healthcare innovation - Korea IT Times

Image Credit:Giovanni Cancemi/Shutterstock.com

Traditional cancer therapies pose the risk of causing damage to healthy tissue as they work to eradicate cancer cells. Scientists are currently working on therapeutics based on nanotechnology to overcome this limitation and increase survival probabilities in several types of cancer.

Nanotechnology enhances chemotherapy and reduces its adverse effects by guiding drugs to selectively target cancer cells. It also guides the surgical resection of tumors with higher levels of accuracy and enhances the efficacy of radiotherapies and other current treatment options. The result is decreased risk to the patient and enhanced survival probabilities.

Researchers are developing novel therapeutics with newly discovered nanoparticles that have novel properties to be leveraged in medical science. While tiny in size, nanoparticles encapsulate small pharmaceutical compounds. The relatively large surface area of nanoparticles allows them to be decorated with ligands, strands of DNA and RNA, peptides, or antibodies. These add-ons give the nanoparticle additional functionality that enhances the therapeutic effect or helps direct a nanoparticle to a specific location. As a result, nanoparticles facilitate combination drug delivery, multi-modality treatment, and theranostic, action (combined therapeutic and diagnostic). The energy absorption and re-radiation properties of nanoparticles also allows them to improve laser ablation and hyperthermia applications, which disrupt diseased tissue.

Nanoparticle research in oncology is currently progressing rapidly, with several major lines of enquiry emerging such as the development of nanoparticle packages, active pharmaceutical ingredients to facilitate the exploration of a broader range of active ingredients, and the establishment of immunogenic cargo and surface coatings as adjuvants to nanoparticle-mediated therapy, radio- and chemotherapy, and stand-alone therapies.

Below, we discuss the major applications of nanotechnology in oncology.

The primary use of nanotechnology in oncology is within the delivery of drugs. Much research has shown that nanotechnology has successfully been used to design multiple systems that improve the pharmacokinetics of a pharmaceutical and reduce the related toxicities. These systems limit the adverse events of the drugs and augment a patients survival chances. They also allow chemotherapies to be more selective as they help deliver the drugs to the specific tumor tissues. These methods involve the development of nano-sized carriers that encompass and deliver the drug to its target.

There are numerous examples of these types of systems. One recent methodology has been used to increase the efficacy of chemotherapy drugs used to treat bowel cancer. The results of clinical trials suggested that the nanoparticle delivery system could help increase survival rates of bowel cancer, the third most common cancer in the world, by helping the delivery of chemotherapy drugs directly to the diseased organs. In studies with animals, the system was proven to be effective at delivering Capecitabine (CAP) to the diseased cells while bypassing healthy cells. This reduced toxic side effects and enhanced the efficacy of tumor reduction activity.

Recent research has demonstrated the efficacy of nano-sized carriers in delivering alternative, herbal-based therapeutics. Scientists have created a novel targeted therapy to treat triple-negative breast cancer (TNBC) that utilizes nano-carriers to help deliver gambogic acid (GA), a Chinese medicine compound, to specific targets. Studies have shown that the novel methodology was effective at enhancing the anti-cancer effect of GA and limiting damage to healthy tissue. As a result, the use of GA may emerge as a more effective therapeutic option for the treatment of TNBC.

Another encouraging area of nanotechnology in oncology is its use in enhancing immunotherapy. While immunotherapy has already been established as an exciting and potentially highly effective treatment option for various types of cancer, the proportion of patients who respond positively to immunotherapy remains low, with only around 15% of patients demonstrating an objective response rate across indications. This is linked to the multiple immune-evasion methods of the tumor.

To help boost the immune systems efficacy against cancer, nanotechnology is being leveraged to manage the spatiotemporal control of the immune system. The idea is that naturally, the immune system is spatiotemporally controlled. Therefore, to work effectively, therapies that impact the immune system should also be spatiotemporally controlled. Recent research has demonstrated that nanoparticles and biomaterials allow scientists to control the delivery, pharmacokinetics, and location of immunomodulatory compounds, generating responses that cannot be elevated by administering the same compounds within a solution.

Radiotherapy is administered to around half of cancer patients at some point during their treatment. Radiotherapy is effective at reducing the size of tumors by exposing them to high-energy radiation, however, this radiation can also damage healthy cells. Scientists have been working on enhancing the effect of radiotherapy, as well as developing novel externally applied electromagnetic radiation. As a result, it is possible that the combination of nanotechnology and radiotherapy may produce more effective results than radiotherapy alone.

How nanoparticles could change the way we treat cancer | Joy WolframPlay

Video Credit: TED/YouTube.com

HKBU and Cornell University develop novel targeted therapy for breast cancer with nanotechnology and Chinese medicine. EurekAlert!. Available at: https://www.eurekalert.org/pub_releases/2021-05/hkbu-hac051121.php

Goldberg, M., 2019. Improving cancer immunotherapy through nanotechnology. Nature Reviews Cancer, 19(10), pp.587-602. https://www.nature.com/articles/s41568-019-0186-9

Targeting Bowel Cancer with Nanotechnology. GEN. Available at: https://www.genengnews.com/topics/targeting-bowel-cancer-with-nanotechnology/

van der Meel, R., Sulheim, E., Shi, Y., Kiessling, F., Mulder, W. and Lammers, T., 2019. Smart cancer nanomedicine. Nature Nanotechnology, 14(11), pp.1007-1017. https://www.nature.com/articles/s41565-019-0567-y

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Follow this link:
The Future of Cancer Treatment Using Nanotechnology - AZoNano

Petri, who serves as Wade Hampton Frost Professor of Medicine and is stepping down as chief of the Division of Infectious Diseases and International Health at UVA, has worked at the University continuously for more than 30 years as a physician, scientist and educator. Last year, he shifted his work to pursue understanding of the coronavirus SARS-CoV-2. He became a trusted voice of reason and comfort to the UVA community extending his knowledge to the nation via online media during the stressful time of the pandemic.

No discussion of Bill would be complete without mentioning what he has done over the last year-plus, during the pandemic, Executive Vice President and Provost Liz Magill said, in presenting the award to him. I can say Jim [Ryan] and I are grateful for his constant availability, tenacity and servant leadership throughout this dark time.

Petri isnt just good at explaining science. Hes also been at the forefront of research, leading a multi-center team effort. He has applied his expertise in vaccine development to produce a mucosally administered, nano-formulated vaccine against the virus responsible for the COVID-19 illness. In addition to his design of the vaccine technology, he is also a most adept and capable team scientist, leading a multicenter effort in this timely, important work, as the citation notes.

Among his responses to this pandemic, he has cared for multiple patients infected with COVID-19, and along the way, educated numerous medical students and young physicians on its medical management.

An expert in infectious diseases, he has focused on several gastrointestinal illnesses and their impact on peoples health and lives, particularly children. Magill pointed out that he is world-renowned for this research, adding, None other than Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the NIH and himself a household name, said, Petri is the worlds premier investigator on diarrhea as well as a consummate physician-scientist, training program director, and institutional leader.

Magill said, His research and publications on understanding and treating these diseases have had life-changing impact for millions of patients the world over.

At UVA, he earned his medical degree and a Ph.D. in microbiology, as well as fellowship training in infectious diseases in the School of Medicine, before returning to join the faculty.

Continue reading here:
Thomas Jefferson Awards Highlight Research and Service to the University - UVA Today

Global Nanobots Market Report Provides Detailed Study Of Industry Players, Business Strategies, Latest Developmental Trends, And Market Growth Rate

The globalNanobots marketreport offers a thorough study of the market in the estimated period. The important players Xidex Corp, Zymergen Inc, Synthace Limited, Ginkgo Bioworks, Advanced Diamond Technologies, Advanced Nano Products Co Limitedin the global Nanobots market are mentioned along with their strong points as well as weak points in this report. It covers almost all aspects of the global Nanobots market including challenges, demand, drivers, and opportunities. The report reviews the impact of these aspects on every market region as well. The value chain analysis and vendor list are also included in the global Nanobots market report.

Ask For Free Sample PDF of Nanobots Market Report

{We Provide Free Sample copy as per your Research Requirement, also including COVID 19 impact analysis}

The global Nanobots market research report emphasizes the presentation of the in-depth market segments {Microbivore Nanorobots, Respirocyte Nanorobots, Clottocyte Nanorobots, Cellular Repair Nanorobots}; {Nano Medicine, Biomedical, Mechanical, Other applications}. The Nanobots market is assessed on the basis of revenue (USD Million) as well. The performance of the important players, vendors, and suppliers influencing the market is also incorporated in the global Nanobots market research report. The majority of the information, together with projected statistics, is presented in the report with the help of tables and graphics. This presentation technique helps the user to understand the market scenario in an easy way.

Various practical tools are used for assessing the development of the global Nanobots market in the future period. The global Nanobots market report offers an outline of the market on a global level. It helps users to decide their next business move and propel their businesses. The index growth and competitive framework of the global Nanobots market over the projected period is involved while reviewing the Nanobots market. The global Nanobots market is also bifurcated regionally North America (the U.S., Canada, and Mexico), South America (Brazil, Argentina, Chile, Colombia), Europe (Spain, Russia, Germany, Italy, France, and UK), Asia-Pacific (Japan, Korea, India, China, Australia, and South-east Asia), The Middle East and Africa (Egypt, South Africa, GCC Countries) as well.

Enquire about COVID-19 Updates for This Report:https://www.marketdataanalytics.biz/global-nanobots-market-report-2020-by-player-region-type-49438.html#inquiry-for-buying

Major Questions Answered in Report:1. Which are the growth factors likely to help the market reach to the next level?2. What is the expected growth rate during the forecast period?3. What are the latest opportunities and challenges for Nanobots market in the future?4. Which are the key market players?

The global Nanobots market is studied in terms of technology, topography, and consumers. The report also covers the market volume during the estimated period. The distinctiveness of the global Nanobots market research report is the representation of the Nanobots market at both the global and regional level.

Key Reasons for Purchasing Global Nanobots Market Report:

New approaches and latest development trend that describe the structure of the market Advanced market breakdown structure Historical data and future market scope In-depth market analysis based on statistics, growth stimulators, and market developments Statistical data representation through figurative, numerical, and theoretical elaboration Report provides insight of the business and sales activities Key competitive players and regional distribution will help find prospective market analytics Report will strengthen the investors decision-making processes

To get more information on this Premium Report::https://www.marketdataanalytics.biz/global-nanobots-market-report-2020-by-player-region-type-49438.html

See the original post here:
Global Nanobots Market 2020 | Research Report Covers | (COVID-19 Analysis) | Industry Research, Drivers, Top Trends | Global Analysis And Forecast to...

NEVE ILAN, Israel, Oct. 29, 2020 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (https://www.nanox.vision/) (Nanox or the Company), an innovative medical imaging company, announced today it has signed an agreement with Ambra Health, a leading medical data and image management cloud software company, to facilitate the transfer of medical images between U.S. hospitals and medical imaging providers.

Per the terms of the agreement, Ambra will serve as the enterprise image exchange solution, integrated with planned U.S. Nanox.ARC system deployments via the Nanox.CLOUD infrastructure, subject to approval of the Nanox.ARC system by the FDA.

The Ambra suite consolidates multiple imaging systems with one flexible, customizable, and low maintenance cloud storage platform that lets medical imaging be accessed securely, anytime, anywhere. Leading facilities use Ambra to connect directly to multiple modalities and imaging systems, creating a unified source of imaging data that is accessible to providers and patients. The unification of imaging data allows for significant daily workflow improvements, opportunities for new research and development, and enhanced communication with patients in image-enabled patient and second opinion portals.

Ambra's network allows providers to seamlessly connect with innovative imaging partners like Nanox. Ambra has over eight billion images under its management and is used in over 50 countries.

"It is our intent to provide seamless image exchange once our systems are approved by the FDA and we commence deployments. By working with Ambra, we can directly connect our modalities at hospitals with imaging providers with minimal integration effort and a high level of data-privacy, said Ran Poliakine, Founder and CEO of Nanox.

Digital health companies like Ambra Health and Nanox are on a mission to streamline the image management process so that critical medical imaging data is available when and where providers need it, said Andrew Duckworth, VP of Business Development at Ambra Health.

About Nanox:Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit http://www.nanox.visio

About Ambra HealthAmbra Health is a medical data and image management SaaS company. Intuitive, flexible, scalable and highly interoperable, the Ambra cloud platform is designed to serve as the backbone of imaging innovation and progress for healthcare providers. It empowers some of the largest health systems such as Memorial Hermann, Johns Hopkins Medicine, UC San Diego and New York Presbyterian, as well as radiology practices, subspecialty practices, and life sciences organizations to dramatically improve imaging and collaborative care workflows. As expert partners, we listen to our customers, understand their needs, and apply our extensive knowledge to deliver innovative medical image management solutions for the future of healthcare, now. Discover what the Ambra medical imaging cloud can do for you at http://www.ambrahealth.com.

Forward Looking StatementThis press release may contain forward-looking statements that are subject to risks and uncertainties. All statements that are not historical facts contained in this press release are forward-looking statements. Such statements include, but are not limited to, any statements relating to the initiation, timing, progress and results of Nanox's research and development, manufacturing and commercialization activities with respect to its X-ray source technology and the Nanox.ARC. In some cases, you can identify forward-looking statements by terminology such as can, might, believe, may, estimate, continue, anticipate, intend, should, plan, should, could, expect, predict, potential, or the negative of these terms or other similar expressions. Forward-looking statements are based on information Nanox has when those statements are made or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Factors that could cause actual results to differ materially from those currently anticipated include: risks related to business interruptions resulting from the COVID-19 pandemic or similar public health crises could cause a disruption of the development, deployment or regulatory clearance of the Nanox System and adversely impact our business; Nanox's ability to successfully demonstrate the feasibility of its technology for commercial applications; Nanox's expectations regarding the necessity of, timing of filing for, and receipt and maintenance of, regulatory clearances or approvals regarding its X-ray source technology and the Nanox.ARC from regulatory agencies worldwide and its ongoing compliance with applicable quality standards and regulatory requirements; Nanox's ability to enter into and maintain commercially reasonable arrangements with third-party manufacturers and suppliers to manufacture the Nanox.ARC; the market acceptance of the Nanox.ARC and the proposed pay-per-scan business model; Nanox's expectations regarding collaborations with third-parties and their potential benefits; and Nanox's ability to conduct business globally, among others. Except as required by law, Nanox undertakes no obligation to update publicly any forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Nanox's expectations.

Media Contacts:

NanoxAlona Steinalona@reblonde.com

Ambra Healthpress@ambrahealth.com888-587-2280

Read the original here:
Nanox Signs With Ambra Health to Enable Image Access and Transfer with US Hospitals and Medical imaging Providers - BioSpace

Global Nano Therapy Marketwas valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of 8.6% during a forecast period.

Market Dynamics

Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanotherapy is a branch of Nano medicine that includes using nanoparticles to deliver a drug to a given target location in the body so as to treat the disease through a process called as targeting.

This report provides insights into the factors that are driving and restraining the global Nano Therapy market. Nanotherapy is also referred to as targeted therapy, which offers to transport the molecules to the affected cells to treat the disease without affecting other negative effects on the healthy cells. Nanoparticles allow for multiple functional groups to be added to the surface. Each of the functional groups contributes to the effectiveness of this method of therapy and deliver its components in a controlled way once it gets to the target cells/tissue. Nano therapy is considered as recent technology for some diseases, which are implemented with the help of submicron-sized molecular devices or nanoparticles. Nanoparticles can improve the drug accessibility in the body with strength, drag out the medication, and can upsurge the half-life of plasma and boost the drug specificity. These are the factors driving the growth of the Nano therapy market.

As compared to the conventional methods, this method has increased more popularity owing to its high accuracy when it comes to administering therapeutic formulations. The market is thriving, with around 250 Nano-medical products being verified or used for humans. Though, with Nano therapy, the carrier is protected from degradations, which allows it to reach given target cells in the body for a local reaction. Nano therapy is considerably used in the treatment of diseases like cancer, diabetes, and cardiovascular diseases. A recent study by the Journal of Diabetes and Metabolic diseases has stated that the incidence of MS ranged from 30.5 to 31.5% in China and 35.8 to 45.3% in India.

However, an absence of controlling standards in the examination of Nano therapy and high expenditure of treatment are several of the major factors that are restraining the growth of the Nano therapy market during the forecast period.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Global Nano Therapy Market Segment analysis

Based on Type, the Nanomaterial segment is anticipated to grow at a CAGR of 20.8% during the forecast period. The nanomaterial is the materials with at least one exterior dimension in the size range of nearly 1 to 100 nanometers. The nanomaterial is intended for developing novel characteristics and has the potential to improve quality of life. The nanomaterial is generally used in cosmetics, healthcare, electronics, and other areas currently. Unceasing development and innovation in the field are impelling the growth of the global nanomaterials market. The amazing chemical and physical properties of materials at the nanometer scale allow novel applications. For instance, energy conservation and structural strength improvement to antimicrobial properties and self-cleaning surfaces. Nanotechnology is being increasingly efficient by spending mainly on R&D activities which are resulting in the development of current technologies and innovations with reference to the new materials.

Global Nano Therapy Market Regional analysis

North America region dominated the Nano therapy market with US$ XX Mn in 2019. The availability of technology, increasing healthcare spending, and government funding for research and development are some of the factors boosting the growth of the Nano therapy market in the region. Europe is expected to follow the Americas and bring in the second leading market share for Nano therapy throughout the forecast period. Europe is mainly driven by awareness and improvement in the nanotechnology sector.

Recent Developments

In 08 May 2019- Cisplatin cis-(diammine) dichloridoplatinum (II) (CDDP) is the first platinum based complex approved by the food and drug administration (FDA) of the United States (US). Cisplatin is the first line chemotherapeutic agent used alone or combined with radiations or other anti-cancer agents for a broad range of cancers such as lung, head and neck.

In May 2019- A new study conducted by scientists from the Indian Institute of Technology, Bombay, have designed hybrid nanoparticles to treat cancer. These nanoparticles are made from gold and lipids. These nanoparticles respond to light and can be directed inside the body to release drugs to a targeted area, and are biocompatible, meaning theyre not toxic to a human body.

In September 2019, researchers at Finlands University of Helsinki, in partnership with the bo Akademi University and Chinas Huazhong University of Science and Technology developed an anti-cancer nanomedicine useful for targeted cancer chemotherapy.

The objective of the report is to present a comprehensive analysis of the Global Nano Therapy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.The report also helps in understanding Global Nano Therapy Market dynamics, structure by analyzing the market segments and project the Global Nano Therapy Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Nano Therapy Market make the report investors guide.Scope of the Global Nano Therapy Market

Global Nano Therapy Market, By Type

Nanomaterial and Biological Device Nano Electronic Biosensor Molecular Nanotechnology Implantable Cardioverter-DefibrillatorsGlobal Nano Therapy Market, By Application

Cardiovascular Disease Cancer Therapy Diabetes Treatment Rheumatoid ArthritisGlobal Nano Therapy Market, By Regions

North America Europe Asia-Pacific South America Middle East and Africa (MEA)Key Players operating the Global Nano Therapy Market

Selecta Biosciences Inc. Cristal Therapeutics Sirnaomics Inc. Nanobiotix Luna CytImmune Science Inc. NanoBio Corporation Nanospectra Biosciences Inc. Nanoprobes Inc. NanoBioMagnetics.n.nu Smith and Nephew NanoMedia Solutions Inc. Nanosphere Inc. DIM Parvus Therapeutics Tarveda Therapeutics

Global Nano Therapy Market Request For View Sample Report Page : @https://www.maximizemarketresearch.com/request-sample/54507

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:Name: Vikas GodageOrganization: MAXIMIZE MARKET RESEARCH PVT. LTD.Email:sales@maximizemarketresearch.comWebsite:www.maximizemarketresearch.com

Originally posted here:
Global Nano Therapy Market- Industry Analysis and Forecast (2020-2027) - Stock Market Vista

Nanoscience has made an impact on a range of industries. With continuous developments, it will only get more exciting for investors.

Through nanotechnology, nanoscience has undeniably impacteda range of industries, from energy to medicine. In the face of continuous nanotechnology research and development, experts are promising an exciting future for the industry.

The terms nanoscience and nanotechnology have been around for a long time, and its common for them to be used interchangeably. However, its important to note that they are not the same.

According toErasmus Mundus, the European Unions higher education program, nanoscience refers to the study, manipulation and engineering of particles and structures on a nanometer scale. For its part, nanotechnology is described as the design and application of nanoscience.

In simple terms, nanoscience is the study of nanomaterials and properties, while nanotechnology is using these materials and properties to create a new product.

Here the Investing News Network provides a comprehensive look at nanoscience investing and nanomaterials, with an overview of the subjects and where they are headed in the future.

The University of Sydneys Nano Institute describes nanoscience as the study of the structure and function of materials on the nanometer scale.

Nanometers are classified as particles that are roughly the size of about 10 atoms in a row. Under those conditions, light and matter behave in a different way as compared to normal sizes.

These behaviours often defy the classical laws of physics and chemistry and can only be understood using the laws of quantum mechanics, the universitys research page states.

The Institute of Nanoscience of Aragon identifies carbon nanotubes (CNTs) as one example of a component that is designed at the nanoscale level. These structures are stronger than steel at the macroscale level. CNT powders are currently used in diverse commercial products, from rechargeable batteries to automotive parts to water filters.

Scientists, researchers and industry experts are enthusiastic about nanoscience and nanoparticles.

As noted in a study published by Jeffrey C. Grossman, a University of California student, quantum properties come into play at the nanoscale level. In simple terms, at the nanoscale level, a materials optical properties, such as color, can be controlled.

Further, the paper states that the surface-to-volume ratio increases at the nano size, opening up new possibilities for applications in catalysis, filtering, and new composite materials, to name only a few.

In other words, the opening up of surface area, which adds new possibilities, can have drastic effects on industries such as manufacturing. New applications in catalysis can allow manufacturing to be sped up, while new composite materials can add more dimension to an end product.

Nanoscale developments could also lead to increased resources and could play a role in the energy sector by increasing efficiency.

As the Royal Society putsit, the aim of nanoscience and nanotechnologies is to produce new or enhanced nanoscale materials.

Nanomaterials are formed when materials have their properties changed at the nanoscale level. Nanomaterials involve elements that contain at least one nanoscale structure, but there are several subcategories of nanomaterials based on their shape and size.

According to the Royal Society, nanowires, nanotubes and nanoparticles like quantum dots, along with nanocrystalline materials, are said to be nanomaterials.

While these are broader classifications of nanomaterials, each of them has several submaterials. Graphene is one popular submaterial and is an example of a nanoplate.

The Integrated Nano-Science & Commodity Exchange, a self-regulated commodity exchange, includes a wide range of nanomaterials and related commodities and lists more than 1,000 nanomaterials.

The exchange states that its entire product range is in excess of 4,500 products, including CNTs, graphene, graphite, ceramics, drug-delivery nanoparticles, metals, nanowires, micron powders, conductive inks, nano-fertilizers and nano-polymers.

As can be seen, nanoscience and nanotechnology are used in a variety of applications across diverse fields, from energy to manufacturing. The University of Sydneys Nano Institute highlights how nanoscienceimpacts manufacturing, energy and the environment through the continuous development of new nano and quantum materials.

With the advancement of materials science and technology, solutions are being worked on for the health and medicine fields, with nanobots gaining popularity in the medical field.

Similarly, nanomaterials like graphene are having a major impact in the technology field graphene is used for various purposes, including in cooling and in batteries.

According to IndustryARC, the global nanotechnology market is projected to reach US$121.8 billion by 2025, growing at a compound annual growth rate of 14.3 percent between 2020 and 2025.

In the US, the National Nanotechnology Initiative, a US government research and development initiative that involves 20 federal and independent agencies, has received cumulative funding of US$27 billion since 2001 to advance research and development of nanoscale projects.

With growth predicted across multiple areas and industries, and with researchers and institutes working on developing the nanoscience field, investors have a slew of nanotechnology stocks to consider.

One popular investment avenue is via graphene, with companies in the space including Applied Graphene Materials (LSE:AGM,OTC Pink:APGMF) and Haydale Graphene Industries (LSE:HAYD). Meanwhile, nanotech stock options include firms such as NanoViricides (NYSE:NNVC), Nano Dimension (NASDAQ:NNDM) and Sona Nanotech (CSE:SONA).

This is an updated version of an article first published by the Investing News Network in 2019.

Dont forget to follow us @INN_Technology or real time updates!

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

Visit link:
What is Nanoscience? | Outlook and How to Invest | INN - Investing News Network

A cheap, safe, self-charging battery that delivers high power for decades without ever needing a charge? That's a game changer. California-based company NDB is making some outrageous promises with its nano-diamond battery technology, which could completely disrupt the energy generation, distribution and provision models if deployed at scale.

Each of these batteries, which can be built to fit any existing standard or shape, uses a small amount of recycled nuclear waste, reformed into a radioactive diamond structure and coated in non-radioactive lab diamonds for safety.

We explained the technology in detail in our original NDB nano-diamond battery breakdown, but we also had the opportunity to speak with members of the NDB executive team. CEO Dr. Nima Golsharifi, COO Dr. Mohammed Irfan and Chief Strategy Officer Neel Naicker joined us on a Zoom call to talk about the technology and its potential for disruptive change.

What follows is an edited transcript.

Dr Nima Golsharifi: Our battery is based on the beta decay and alpha decay of radioisotopes. The technology we have encapsulates this radioisotope in a very safe manner, which allows it to be used in basically any application that current batteries are being used for.

Loz: The particular type of carbon that you're using, where do you get that?

Nima: Basically we're using a range of different isotopes, not just one particular one, but access to these are through different methods. We have some partners in collaboration at the moment that can provide us with them.

But they're basically taken from nuclear waste. So we can recycle them and use the raw materials for our application. But we can also synthesize it in large scale in our facility. So both are possibilities.

Loz: OK. So what part of a nuclear reactor creates this waste? What's it doing before it becomes waste?

Nima: Basically, some parts of the nuclear reactor, like the moderator and the refractor, are being exposed to radiation from the fuel rods. Over time they become radioactive themselves. That's the part that they have to store as nuclear waste.

So this part could be taken away, and through some process, either gasification or some other processes we've designed, we can convert that into a useful raw material for our batteries.

Sheikh Mohammed Irfan: Dr. Nima, maybe you can also talk about how big of a waste problem that is for the nuclear industry currently.

Nima: Sure. At the moment, their expenditure is more than a hundred million dollars every year. Nuclear waste is a very large issue across the world. And beside this, there's basically no other way to re-use it in a safe solution.

So what we're doing covers two challenges in one. Converting nuclear waste into a battery that generates power in a very safe manner. Once this battery is used and it can have a very long life span it becomes a very safe byproduct that's of no harm to the environment.

Loz: Right. So I saw a number somewhere that these batteries can last for 28,000 years.

Nima: Let me correct that. It depends on the type of radioisotope you're using, and for every application the lifetime is different. But what we can say is that the battery would operate for the lifetime of the application itself, for sure. For some applications, much higher. So if you're talking about electric vehicles, our battery could run for around 90 years without the requirement of recharging.

When it comes to something like consumer electronics, it'd be more like 9 years. In some small sensor applications, it can go for up to 28,000 years.

NDB

Loz: I understand. So what sort of quantities of this waste are there around the world? Is this super common stuff, or is it reasonably finite?

Nima: Basically we're covering two different kinds of nuclear waste. One is intermediate, and the other is high level. So there will be a time where we have recycled the entire amount of nuclear waste, and we'll need new solutions for the raw material. But as I mentioned, we'll be able to produce this raw material through other methods, including transmutation.

That's a process that's currently being used, and not something we've invented ourselves. It was invented by MIT, and it involves a centrifuge to separate out the isotopes. The main ingredient is nitrogen, which is the major component of air, so it's a very cheap solution.

Loz: So you've got your nuclear waste, it's obviously dangerous for humans. How does it become safe to be used in a battery?

Nima: Basically, we can generate a high amount of cover from the radioactive substance. We're using a combination of technologies within our structure that can make it very safe to users. Mainly it comes down to the fact that we're using diamond structures.

Diamond itself has different interesting properties. It's one of the best heat sinks available at the moment, for example. That on its own covers thermal safety. When it comes to mechanical safety, diamond is one of the strongest materials in the world. 11.5 times stronger than steel. So again, that itself makes the battery tamper-proof and safe.

In addition to that, we have a combination of other technologies, including the implantation of the radioisotopes within the diamond structure, which stops the spread of the radioisotopes even if the structure is broken down which is kind of impossible without access to specific tools like lasers and others.

So in general I can say it's a combination of technologies that we've either innovated or invented that create a very safe structure as a battery.

Irfan: I'd like to add to that, that using radioisotopes as a source for energy is not new. We have nuclear medicine, where patients are treated with controlled equipment, which has always given effective results. Similarly, we have had nuclear-powered submarines and aircraft carriers. Of course, that's a completely different process, but it's been able to successfully and safely deliver power and energy without safety issues.

What Dr. Nima has highlighted is that the choice of diamond as a material is one of the strongest natural materials, and it acts as a powerful shielding and protection mechanism.

Loz: Right. Can you describe how the energy is extracted and harnessed?

Nima: Maybe I can give an example that could help you understand. Let's go to solar cells, everyone's familiar with those. These convert the energy from light radiation into electricity in photovoltaic cells.

In our case, we're converting the radiation from alpha/beta decay alpha and beta radiation directly into electricity. And the mechanism we're using is simple crystalline diamond. As I mentioned before, we have another layer, which is fully crystalline diamond, creating extra shielding and safety for this structure.

Neel Naicker: What Nima's describing is how the radioactivity produced by the body is actually more than what you get from these batteries. They're quite safe.

Loz: So in terms of evaluating batteries for use in cars, eVTOLs and things like that, the main metrics seem to be energy density, power density, safety in a crash, that sort of thing. Do you know what sort of figures you're looking at with these batteries?

Nima: When it comes to energy density, the energy density of a basic radioisotope is far beyond anything else on the market.

When it comes to power density, the solution we have will give a higher level. But compared to the way that energy density is higher, power density is not that much higher. But it's still significantly better than other batteries in the market.

And as far as crashes, no crash could break down our structure at all. Because you're using the diamond, and the specific mechanisms that make it stronger. The only way to get through the structure we have is the use of specific tools and lasers, which are quite expensive.

Neel: Another way to look at this is to think of it in an iPhone. With the same size battery, it would charge your battery from zero to full, five times an hour. Imagine that. Imagine a world where you wouldn't have to charge your battery at all for the day. Now imagine for the week, for the month How about for decades? That's what we're able to do with this technology.

Loz: It would strike at the heart of the disposable model the phone companies tend to use.

Neel: You've hit the nail on the head there. A couple of things. One is the ability for us to power things at scale. We can start at the nanoscale and go up to power satellites, locomotives Imagine that.

Secondly, we're taking something that's a big negative radioactive waste, very dangerous and turning it into something productive that provides electricity.

The third thing is that we wanna use this technology to get low-cost electricity to places that need it. We've now disrupted the whole mechanism of the creation and storage of power. There's a lot of infrastructure needed before you can flip a light switch and a light comes on.

But with what we've created, you don't need that infrastructure. You could put one of these batteries in a home, and boom, you've eliminated the whole infrastructure. Imagine the disruption that's gonna cause, for good or for bad. It'll upset a few people.

We've taken something that's really harmful to the environment, a problem, and created energy. And for places that don't have the electrical infrastructure in place, we want to provide that at a very low cost.

NDB

Loz: Let's talk about cost a little. Obviously lithium batteries cost a lot, they're a primary component of the cost of electric vehicles. Do you guys have a sense for what these things could cost in a commercial environment?

Nima: Yes, we've done financial modelling around this. A lot of applications have been considered. What we can say is it'll depend on the application, but it should be at a good competition level with current lithium-ion batteries.

In some cases, you're a little bit higher in price for production, and in others, when it goes to scale, we're a cheaper solution. Let me give you an example. Take the battery for a Tesla car, it costs somewhere in the region of US$9-10K. Our battery will cost something in the region of US$7-8K. But it's different in different applications.

Loz: So, cheaper and it never needs charging, and it lasts for vastly longer than any lithium cell.

Irfan: Not only is it a few thousand cheaper for the battery pack, but ours recharges itself. So on a Tesla, you need to recharge, stop, over time the battery wears itself out. Ours lasts for a long time.

We'll probably have them available under some sort of subscription model, pay as you go, but it'll be substantially cheaper than what the mechanism is today for a Tesla car.

Loz: Extraordinary. How far along is this technology? How far are we off mass production? Where are you at with prototyping and testing?

Nima: We're in the prototyping stage at the moment. We've completed the proof of concept, and we're about to start the commercial prototype. However, the pandemic has happened, and the lab has been shut down for some time.

But basically once the laboratories are open, we do require around 6-9 months to complete our commercial prototype, and following that to go through the regulatory process, to bring the first few applications for the battery into the market in less than two years' time.

Loz: So it's not far off.

Neel: Just to give you an example, we'll take Google, which has data centers all across the world. Amazon, Facebook, all of these companies. In confidential conversations we've had with some of these parties, we've spoken about how they use and dispose of more Uninterruptible Power Supplies (UPS) than anyone on the planet. Google always has to be on. And those UPS units have a use by date, they have to discard them.

Our product will be able to support that, while reducing the carbon footprint, and lasting far, far longer. That's a game changer when you consider how big an operation something like AWS is. It'll be a huge product for that.

A secondary product will be for the satellite market, where there'll be no regard for whether it's radioactive or not. Low-power satellites, we'll be able to power those for a long, long time without having any regard to whether they're facing the Sun, or getting any Sun on their solar panels, or whatever.

It changes the whole dynamic. Not only have we disrupted the whole energy infrastructure for creating and delivering power, we can also make big changes to the business model for a lot of companies. Big concerns can just become negligible.

This will change a lot of industries. In the future, we could look at using these to power nanorobots moving inside the body. It works from the nanoscale up to large scale. We think it'll be very impressive.

Loz: So the limits on this technology will be what, availability of the raw materials? Regulations? Do you see any regulatory barriers?

Irfan: It's a good question. We've done a comprehensive study on the regulatory and compliance aspects of our technology. Fortunately there are other devices already on the market that use radioisotopes and radioactive material inside them. Some are in the medical industry, like pacemakers. There are already different types of regulations in place.

So the matter here would be our design complying to those regulations, and we've been doing that over time.

Neel: In your home, you'll have smoke detectors, right? All of those have the same radioactivity as well. That's one point.

When it comes to availability, there's enough raw materials out there that we can develop for a long time. That's not the issue. Also, on the regulatory side there are some markets we can go into immediately without any concerns there. Aerospace, military, many others where there aren't the same requirements for compliance.

For a car, it may be different. For a hearing aid, it may be different, or a consumer product. But there are some applications where it won't be a problem at all.

Loz: Right. This is perhaps a bit of a crass question to ask, but do you guys have to pay for this nuclear waste, or are people paying you to take it away?

Irfan: (Laughs) I'm glad you brought that up! We've got a few places that have offered to pay us to take it away. It's a nuisance for them. They have to store it, and you can imagine the regulations around that. In many cases, they have to keep the public a certain distance away. They'll actually pay us to take this stuff away.

So it's a secondary opportunity for us from a revenue standpoint, and we've discussed this with several partners.

Loz: What a wonderful business to be in, where you're paid to take your own raw materials.

Neel. I wanna drive one thing home. If you take a look at the map of energy use in the world, and the map of wealth in the world, they're very similar. One thing we're trying to do with our application is trying to get some of these devices out to places where kids don't have electricity to do their homework, or to power clean water technology.

We're very adamant that this be a component of our business. And while we can't mention too many names, we've spoken with several big partners who would support this effort. Some of these companies feel they need to do good in the world, and providing electricity to places across the world that don't have it is a great opportunity for them.

Again, they don't have the huge infrastructure in place. But we don't need the infrastructure. We don't need power stations, or power lines, or any of that, to provide power. We're adamant as a team that we will give back in a major way that today's infrastructure won't allow.

Loz: In terms of the IP around this, how much do you guys own, and how much competition do you expect?

Irfan: Right now, we have patents pending around our technology. I think we're quite ahead of the competition that exists in the market, we started much earlier than the others and our technology is more advanced.

We thank the NDB team members for their time and look forward to learning more as development progresses.

Source: NDB

See more here:
Interview: The NDB team on its revolutionary nano-diamond batteries - New Atlas

Dublin, Aug. 12, 2020 (GLOBE NEWSWIRE) -- The "Nanotechnology Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Nanotechnology includes fields of science as diverse as molecular nanotechnology, surface science, organic chemistry, molecular biology, semiconductor physics, energy storage, micro-fabrication, and molecular engineering. The technology finds applications in a gamut of industries such as medicine & healthcare, environment, ICT, energy, nano-EHS, and others. A key application of nanotechnology is found in electronics and semiconductor products segment, which is estimated to grow at a substantial CAGR of 15.01% through to 2025.

Nanotechnology Market Growth Drivers:

Nanotechnology Market Trends:

Nanotechnology Market Challenges:The most challenging aspect in the nanotechnology market is scalability of production. Even though nanomaterials impart an outstanding functional performance in the laboratory or prototype stage, the scalability factor is dwarfing the nanotechnology market size. Hence, some of the most propitious applications are in the R&D stage. However, in the future, significant developments are expected in the application of nanotechnology with a profitable commercialization in the automotive, aerospace, and sporting goods industry. Furthermore, the technology will help in effective treatment of cancer which will support the vendors in the nanotechnology market.

Nanotechnology Market Research Scope:The base year of the study is 2020, with forecasts up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the nanotechnology market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The nanotechnology market research report also analyses the application of the same in various industries by product type that includes nano composites, nano devices, nano tools, nano materials, and others.

Key Topics Covered:

1. Nanotechnology Market - Overview2. Nanotechnology Market - Executive summary

3. Nanotechnology Market

4. Nanotechnology Market Forces

5. Nanotechnology Market -Strategic analysis5.1. Value chain analysis5.2. Opportunities analysis5.3. Product life cycle5.4. Suppliers and distributors Market Share

6. Nanotechnology Market - By Type (Market Size -$Million / $Billion)6.1. Market Size and Market Share Analysis 6.2. Application Revenue and Trend Research6.3. Product Segment Analysis

7. Nanotechnology Market - By Applications (Market Size -$Million / $Billion)7.1. Introduction7.2. Medicine and Healthcare Diagnosis7.3. Environment7.4. Energy7.5. Information and Communication Technologies7.6. Nano-EHS

8. Nanotechnology - By End Use Industry(Market Size -$Million / $Billion)8.1. Segment type Size and Market Share Analysis 8.2. Application Revenue and Trends by type of Application8.3. Application Segment Analysis by Type

9. Nanotechnology - By Geography (Market Size -$Million / $Billion)9.1. Nanotechnology Market - North America Segment Research9.2. North America Market Research (Million / $Billion)9.3. Nanotechnology - South America Segment Research9.4. South America Market Research (Market Size -$Million / $Billion)9.5. Nanotechnology - Europe Segment Research9.6. Europe Market Research (Market Size -$Million / $Billion)9.7. Nanotechnology - APAC Segment Research9.8. APAC Market Research (Market Size -$Million / $Billion)

10. Nanotechnology Market - Entropy10.1. New product launches10.2. M&A's, collaborations, JVs and partnerships

11. Nanotechnology Market Company Analysis11.1. Market Share, Company Revenue, Products, M&A, Developments11.2. include Nanosys11.3. QD Vision11.4. Arkema11.5. 10Angstroms11.6. 10x MicroStructures11.7. 10x Technology Inc11.8. 3M 3rd Millennium Inc11.9. 3rdTech Inc

For more information about this report visit https://www.researchandmarkets.com/r/r2psqq

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

See the article here:
Opportunities in the World Nanotechnology Market to 2025 - Application of Nanotechnology in Wastewater Treatment and Enhanced Renewable Energy Driving...